Dairy Goats endoparasites infection and effects of commercial homeopathy medicine

Background: The gastrointestinal helminths parasitism may limit the production because it represents the greatest economic loss in goat (Mandonnet, 2005). The most common treatment against the worms currently is the use of antiparasitic class drugs. However, indiscriminate use of these substances led to the selection of resistant populations of helminths for all anthelmintics groups, increase the cost of production, leaves toxic residues in animals and environment. These facts lead to the new demands, in which homeopathy is inserted (Macleod, 1991). Among the advantages, one can minimize the use of pesticides, reduce the risk of the resistance to conventional antiparasitic substances, prolongs active life of the active principles without pharmacological residues in milk or goat meat. Aims: The study evaluated the parasitic load of endoparasites by FEC in a goat herd with the use of commercial homeopathic product CapriOvi Verm100 of RealH manufacturer. Methodology: Sixteen (16) young female goats (Capra aegagrus hircus) 7 months old were assessed weekly to Fecal Eggs Count (FEC) determined in triplicate McMaster Egg Counting Technique during two months. All dairy animals had predominance of Alpine and Saanen breeds. All animals received albendazole anthelmintic drenching before treatment and routine handling of the goats was maintained for all animals to mimic the conditions in the field. They were housed in the same pen with wood sawdust bedding. The mixed natural infection was controlled by exclusive access to the paddock star grass with time restrictions. Breeding season occurred at 8 months age. The animals were distributed in a randomized block design by the average of four weekly FECs prior to treatment. The commercial product CapriOvi Verm100 RealH (Brazil) was individually orally administered (10g/animal/day), 6 days a week, during 2 months.0 Results: The effect of the product show to reduce the animals OPGs by the half part after a month of use during early-mid pregnancy. A two-way ANOVA showed that the treatment affected the results [F 1/103 = 33.05, p < 0.0001] as the time does [F 1/103 = 3.35, p = 0.003]: there was no interactions between the factors [F 1/103 = 0.1.41, p = 0.21]. Using the same pen for the animals treated and control provided a challenging situation for greater than when treating all animals collectively. Long-term tests should be performed to determine its effects and its long-term strategic interaction with conventional medicines because it seems to increase the safety of the animals to infection. Homeopathy treatment kept the FEC levels similar to those found initially; differently, control group presented increase in FEC values in function of time. Conclusion: The product CapriOvi Verm100 RealH shown to reduce the FEC in goats during a month of use in the early and middle third of gestation nulliparous dairy goats.